Blockchain

PIN AI secures $10M from a16z CSX, Hack VC, and All-Star angels to launch open platform for personal AI

on

    More in Blockchain:

    San Francisco, United States, September 9th, 2024, Chainwire

     

    Innovative startup from Ethereum Core research, Google Brain, Stanford, MIT, and CMU aims to democratize on-device intelligence, empowering users with control over their personal AI, and receiving investment from a16z CSX, Hack VC, and investors from projects like Solana, Polygon, Near, Worldcoin, etc.

    PIN AI, a pioneering AI infrastructure company, announces $10 million in pre-seed funding to develop the world’s first open-source Personal Intelligence Network (PIN). A16z CSX, Hack VC, and notable investors, including Blockchain Builders Fund (Stanford Blockchain Accelerator), Illia Polosukhin (Transformer paper author; Founder, NEAR Protocol), Anagram/Lily Liu (President, SOL Foundation), Symbolic Capital (Co-Founder, Polygon), Evan Cheng (CEO, Mysten Labs/SUI), dcbuilder (Worldcoin Foundation), Foresight Ventures (parent company of the Block), Nomad Capital, Tim Shi (Co-Founder, Cresta), Ben Fisch (CEO, Espresso), Scott Moore (Co-Founder, Gitcoin), Alumni Ventures, and Dispersion Capital, have backed the project.

    Offering an open-source, web3-enabled alternative to Apple Intelligence, PIN AI’s platform turns smartphones into privacy-focused AI personal assistants. By redirecting profits from users’ data and attention, it empowers users to regain control and monetize their data. The platform leverages personal, contextual data and cryptography, deploying cutting-edge AI models on-device to handle tasks across apps—like shopping, ordering food, wealth management, and interacting with centralized exchanges, DeFi, and prediction markets.

    This AI-driven assistant ensures robust privacy and user-controlled data management, disrupting ultra-profitable models of web2 giants, including Apple’s 30% app revenue cut (over $100 billion) and Google’s mobile ads and Android store revenue cuts.

    Davide Crapis, Co-Founder leading Protocol Research, said, “We’re building a movement towards an open-source future where personal AI assistants can work on PIN AI’s platform like smart contracts on Ethereum.” He added, “PIN AI will take back the $100b+ profit from tech giants and return it to users, allowing them to control and monetize their data. Our platform offers access to a wider range of AI agents, developed by the open-source community, capable of handling tasks across popular apps.”

    PIN AI’s mission is to foster innovation for personal AI agents by offering access to personal, contextual data that reflects individual users’ needs and preferences. Unlike closed ecosystems like Apple, PIN AI’s open platform connects privacy-protected user data via a Layer-2 blockchain. This enables more flexibility in AI application development without the constraints of traditional, closed systems.

    Bill Sun, Co-Founder and Chief Scientist, said, “On-device multi-modality models will revolutionize daily life. We are building a personal index for each user to create an on-device model that evolves via distributed training on the user’s phone. Soon, users won’t need to open multiple apps to complete tasks. The personal AI assistant will understand preferences and manage tasks efficiently.” PIN AI’s assistant will connect users with apps and services bidding on its blockchain protocol to fulfill tasks like shopping or crypto activities.

    PIN AI shifts data monetization from big tech to users, allowing secure monetization of personal data. Users receive token incentives through data onboarding and intent fulfillment, only providing necessary data with matched Personal AI Agents, while maintaining control of their information.

    At launch, PIN AI partners with Worldcoin and is developing a front-end product similar to Siri, expanding its reach and enhancing user experience.

    Leading the team are co-founders Davide Crapis and Ben Wu. Crapis, formerly of Ethereum Core Research, leads Protocol Research. Ben Wu, heading Strategy, is an MIT graduate, Y Combinator alum, and serial entrepreneur. The technical leadership includes Bill Sun, a Stanford AI/Math PhD and early Google Brain researcher, as Chief AI Scientist, and Regan Peng, a CMU graduate and former lead at Didi Fintech and Yahoo Data Infra, as Founding Head of Engineering.

    PIN AI collaborates with a16z crypto research, Flashbots, Espresso Systems, and academics from Stanford, Columbia, and NYU. Ben Wu emphasized the importance of an open platform, saying, “The open internet has made large language models possible. We need to build an open platform for users on their trusted device, allowing access to their various data, making their Personal AI possible.” Unlike Apple Intelligence, PIN AI’s system can run on low-spec smartphones by dynamically shifting between edge AI (on-device) and server AI to optimize performance, ensuring wide accessibility.

    The funding will expand research, grow the team of AI and blockchain experts, and accelerate the deployment of PIN AI’s technology. The company will join the a16z CSX Fall 2024 cohort in New York City.

    About PIN AI

    PIN AI is developing an open-source personal AI operating system that leverages smartphone and app data to empower users with control and privacy. The company’s approach aims to connect AI developers with users, promoting data sovereignty and developer empowerment. PIN AI collaborates with Ethereum Core Research and is committed to privacy and innovation.

    For more updates, visit pinai.io, X (formerly Twitter), Telegram, Discord, and Linkedin.

     

    Contact

    PIN AI
    contact@pinai.io

    PostAd_coinrule_banner728x90

    Leave a Comment

    Your email address will not be published. Required fields are marked *

    *

    Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection

    2024-09-17T13:00:00Z

    Assessment by specialist AI team from “PersonalAIze” Highlights the Strength, Potential, and Visionary Talent Behind the Innovative Software as a Service (SaaS) Platform

    AMSTERDAM, Sept. 17, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RENB) - PersonalAIze, a cutting-edge company in AI and machine learning applications for healthcare, has conducted a comprehensive evaluation of RenovaroCube’s advanced AI platform. This effort is spearheaded by PersonalAIze CEOs and AI experts, Mark Hoogendoorn and Sandjai Bhulai, who bring their extensive expertise to assess the platform developed under the guidance of Frank van Asch, CTO and co-Founder of the technology on which RenovaroCube is based.

    Prof. Mark Hoogendoorn, also a professor of Artificial Intelligence, expressed his enthusiasm: “We were pleased to be engaged to make an assessment of the AI platform; this is exactly the area of PersonalAIze’s expertise.”

    Frank van Asch remarked on the collaboration, “The expertise of PersonalAIze’s team is exceptional, and their positive evaluation of our AI/ML platform is invaluable.”

    RenovaroCube's AI platform has been advancing innovation for the past 12 years, evolving from its award-winning Fintech roots into a potentially groundbreaking multi-omic molecular differential system that identifies cancer in its earliest stages. It is an open platform that can be used as a SaaS by many private sector and academic or other large hospital and health systems. It is also disease agnostic, so it can be expanded for many purposes.

    The initial aim is to transform cancer early detection and early detection of recurrence from a small vial of blood (liquid biopsy), potentially supporting clinicians to initiate treatments as soon as possible towards improved outcomes for patients.

    In their analysis, PersonalAIze noted the platform's focus on liquid biopsies and third-generation sequencing coupled with AI techniques as highly promising, potentially allowing for comprehensive analysis across varying cancer types and stages. Prof. Sandjai Bhulai, also a professor of Mathematics, commented on the platform’s unique potential and the impressive multidisciplinary team at RenovaroCube under Frank van Asch’s leadership.

    Based on these findings, PersonalAIze is eager to collaborate further with RenovaroCube to enhance and commercialize the platform.

    PersonalAIze aims to contribute in several key areas:

    • Advancing AI models by leveraging the latest state-of-the-art techniques.
    • Supporting the professional growth of the software team.
    • Enhancing the explainability of AI models, engaging clinicians in model development.
    • Selecting optimal patient groups for data collection and evaluating models and final products in clinical settings.

    This partnership could represent a substantial step forward in the fight against cancer, bringing together AI innovation and healthcare expertise to develop a powerful tool for early detection that has the potential to save countless lives.

    About Renovaro
    Renovaro aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro Inc. includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube.

    RenovaroCube has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments. RenovaroCube intervenes at a stage where potential therapy can be most effective. RenovaroCube is a molecular data science company with a background in FinTech and a 12-year history. It brings together proprietary artificial intelligence (AI) technology, multi-omics, multi-modal data, and the expertise of a carefully selected multidisciplinary team to radically accelerate precision medicine and enable breakthrough changes in cancer care.

    About PersonalAIze
    PersonalAIze focusses on building solutions that improve healthcare by leveraging state-of-the-art AI techniques. It has been founded by four experienced professors bringing together decades of research experience in AI and healthcare with the aim to bring the latest scientific AI developments into healthcare practice faster. PersonalAIze does this through both consultancy and product development and targets clinical decision making systems as well as improvement of health care operations such as capacity planning.

    Forward-Looking Statements

    Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline, platform and fundraising. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as “believes,” “plans,” “expects,” “aims,” “intends,” “potential,” or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Renovaro’s most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Renovaro Inc. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

    For media inquiries, please contact: karen@renovarocube.com

    Source: Renovaro Inc.


    GlobeNewsWire News

    Recent Comments